"The Company’s clinical programs continue to gain global interest and momentum". It would be good to know what that part of the statement means, but hopefully means that pharma is starting to take notice.
- Forums
- ASX - By Stock
- PTX
- Ann: September 2018 Appendix 4C - Quarterly
Ann: September 2018 Appendix 4C - Quarterly, page-2
-
- There are more pages in this discussion • 5 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PTX (ASX) to my watchlist
(20min delay)
|
|||||
Last
4.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $32.21M |
Open | High | Low | Value | Volume |
4.0¢ | 4.1¢ | 4.0¢ | $22.35K | 558.4K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
6 | 221774 | 3.9¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
4.1¢ | 860576 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 249700 | 0.043 |
3 | 145000 | 0.042 |
6 | 477461 | 0.041 |
7 | 247800 | 0.040 |
3 | 130000 | 0.039 |
Price($) | Vol. | No. |
---|---|---|
0.046 | 99540 | 2 |
0.047 | 18686 | 2 |
0.048 | 200000 | 1 |
0.049 | 194091 | 3 |
0.050 | 427445 | 9 |
Last trade - 14.51pm 19/11/2024 (20 minute delay) ? |
PTX (ASX) Chart |